Your gift is 100% tax deductible
Chemotherapy for Bone Cancer
Chemotherapy (chemo) is often an important part of treatment for Ewing sarcoma, osteosarcoma, and undifferentiated pleomorphic sarcoma (UPS).
It is not used as often for most other types of bone cancers, like giant cell tumors and most types of chordomas and chondrosarcomas. These cancers aren’t very sensitive to chemo, so other medicines might be tried first instead.
Chemo is the use of drugs to treat cancer. These drugs are usually given into a vein (IV) and can reach and destroy cancer cells anywhere in the body.
Note: This information focuses on bone cancers that are seen most often in adults and start in the bones (primary bone cancers). Osteosarcoma, Ewing sarcoma, and bone metastases are covered separately.
Which chemo drugs are used to treat bone cancer?
Some of the chemo drugs that can be used to treat bone cancer include:
- Doxorubicin (Adriamycin)
- Cisplatin
- Etoposide (VP-16)
- Ifosfamide
- Cyclophosphamide
- Methotrexate
- Vincristine
- Dactinomycin
- Topotecan
- Irinotecan
- Temozolomide
- Lurbinectidin
- Carboplatin
- Gemcitabine
- Docetaxel
In most cases, 2 or more drugs are given together. Some common combinations include:
MAP regimen: High-dose methotrexate, doxorubicin, and cisplatin, sometimes with ifosfamide and/or etoposide (MAPIE). This is most commonly used to treat osteosarcomas and undifferentiated pleomorphic sarcomas of the bone (UPS).
VDC/IE regimen: Vincristine, doxorubicin, cyclophosphamide, ifosfamide and etoposide. This combination is used most often to treat Ewing sarcoma.
Possible side effects of chemo
Chemo drugs affect cells that grow fast. While cancer cells grow fast, other healthy cells in the body do too. This includes blood-forming cells, hair cells, and cells that make up the lining of your gut. When chemo damages these fast-growing healthy cells, it can lead to side effects.
These side effects vary depending on the type of chemo drugs, the dose, and the length of time they are given.
Your cancer care team will watch you closely for side effects. Don’t hesitate to ask questions.
Common short-term side effects
Some common short-term side effects of chemo drugs include:
- Nausea and vomiting
- Loss of appetite
- Diarrhea or constipation
- Hair loss
- Mouth sores
Chemo can damage your bone marrow, where new blood cells are made. This can lower your blood cell counts, leading to:
- Increased chance of infection (from having too few white blood cells)
- Easy bleeding or bruising (from low platelets)
- Fatigue or shortness of breath (from low red blood cells)
Controlling short-term side effects
To lower the risk of serious infections, drugs called growth factors (such as filgrastim, also known as G-CSF) are sometimes given along with chemo to help your body make new white blood cells as quickly as possible.
Most short-term chemo side effects go away after treatment is finished. Often there are ways to make these side effects less severe during treatment.
For example, you can take medicines to help prevent and reduce nausea and vomiting or to help your blood counts return to normal levels. Talk to your cancer care team if you have any questions about chemo side effects. Tell them about any side effects you have so they can help you control them.
Long-term side effects
Chemotherapy can also have some longer-term side effects.
For example, some drugs can increase the risk of later developing another type of cancer, such as leukemia. This risk is serious, but it isn’t common. The small increase in risk must be weighed against the importance of chemotherapy in treating bone cancers.
For more on the possible long-term effects of treatment, see After Treatment for Bone Cancer.
Side effects of specific chemo drugs
Some chemo drugs have specific side effects. For example:
Doxorubicin (Adriamycin) can damage your heart muscle. This risk goes up with higher doses of the drug, so your cancer care team will watch your heart carefully during treatment and limit your total dose of doxorubicin.
Most of the time, a drug called dexrazoxane is given with chemo to lower the risk of side effects.
Cisplatin and carboplatin can cause nerve damage (neuropathy), leading to numbness, tingling, or pain in the hands and feet. This often goes away or gets better once treatment stops, but it might last a long time in some people.
These drugs can sometimes affect hearing, especially high-pitched sounds.
Kidney damage can also occur after treatment. Getting lots of fluids before and after you take these drugs can help prevent this.
Ifosfamide and cyclophosphamide can damage the lining of your bladder, which can cause blood in your urine. The risk of this happening can be lowered by taking the drugs with plenty of fluids and a drug called mesna, which helps protect the bladder.
These drugs may also damage the ovaries and testicles, which can affect their ability to make sex hormones like estrogen and testosterone. Low sex hormones can impact sexual desire or pleasure, and in younger people it can lead to early menopause or infertility. Low sex hormones can also impact bone health, energy, and your brain’s ability to create new memories or complete tasks.
Etoposide can increase the risk of later developing a second cancer like acute myeloid leukemia (AML), which is a cancer of white blood cells. Fortunately, this is rare.
Vincristine can cause nerve damage (neuropathy), leading to numbness, tingling, or pain in the hands and feet. This often goes away or gets better once treatment stops, but it might last a long time in some people.
More information about chemotherapy
For more general information about how chemotherapy is used to treat cancer, see Chemotherapy.
To learn about some of the side effects listed here and how to manage them, see Managing Cancer-related Side Effects.
- Written by
- References
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Gelderblom AJ, Bovee J. Chondrosarcoma. UpToDate. 2025. Accessed at https://www.uptodate.com/contents/chondrosarcoma on October 8, 2025.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Bone Cancer. v.1.2026 – September 11, 2025. Accessed at https://www.nccn.org/professionals/physician_gls/pdf/bone.pdf on October 7, 2025.
National Cancer Institute. Ewing Sarcoma Treatment. Accessed at https://www.cancer.gov/types/bone/hp/ewing-treatment-pdq on October 7, 2025.
National Cancer Institute. Osteosarcoma and UPS of Bone Treatment. Accessed at https://www.cancer.gov/types/bone/hp/osteosarcoma-treatment-pdq on October 7, 2025.
Stacchiotti S, Gronchi A, Fossati P, et al. Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group. Ann Oncol. 2017;28(6):1230-1242.
Stacchiotti S, Sommer J; Chordoma Global Consensus Group. Building a global consensus approach to chordoma: a position paper from the medical and patient community. Lancet Oncol. 2015;16(2):e71-e83.
Last Revised: January 5, 2026
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.


